Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sci_guy
    Member
    • Jan 2008
    • 83

    Postdoctoral Fellow (Epigenetics Liquid Biopsy Markers) - CSIRO, Sydney, Australia

    Postdoctoral Fellowship on a project seeking to find and characterise circulating cell-free DNA biomarkers of traumatic brain injury.
    • Based at CSIRO, Sydney, NSW, Australia
    • AU $78k to $88k plus up to 15.4% superannuation
    • 3 year term.
    • Translational focus


    Essential Criteria:
    1. Demonstrated knowledge and understanding of molecular biology.
    2. Demonstrated knowledge and experience in bioinformatics for the analysis and interpretation of multi-dimensional datasets.
    3. Demonstrated proficiency in at least one data analysis language: R, Python, MATLAB.
    4. Willingness to work across regionally dispersed, multi-disciplinary research teams and institutions across Sydney and Brisbane and the motivation and discipline to carry out autonomous research.
    5. A record of science innovation and creativity, plus the ability and willingness to incorporate novel ideas and approaches into scientific investigations.


    Desirable Criteria:
    1. Knowledge of epigenetics.
    2. Experience in undertaking lab procedures with bisulfite-treated DNA. E.g. Methylation-specific PCR, bisulfite amplicon library preparation.
    3. Experience with Unix shell or a scripting, interpreted or compiled language: Python, Ruby, Perl, C++, Java, Scala.
    4. A knowledge of commonly used genomics tools for working with deep sequencing data.


    The Postdoctoral Fellow appointed to this role will join CSIRO’s Probing Biosystems team to undertake a Future Science Platform (FSP) project led by Dr Jason Ross. This project seeks to find and characterise circulating cell-free DNA biomarkers of traumatic brain injury with the translational goal of developing a clinical biomarker in this space. The Epigenetics Team in North Ryde, NSW has a long history in DNA methylation biomarker development, including the co-development of Colvera™ with the Clinical Genomics company. Colvera™ is a biomarker product for diagnosing and monitoring the recurrence of colorectal cancer.

    Postdoctoral Fellowships at CSIRO provide opportunities to scientists and engineers, who have completed their doctorate and have less than three years relevant postdoctoral work experience. These fellowships will help launch their careers, provide experience that will enhance their career prospects, and facilitate the recruitment and development of potential leaders for CSIRO.

    Applications close: 31 Jan 2017

    For more information and to apply, please download this position description document.
    Last edited by sci_guy; 01-02-2017, 05:25 PM. Reason: To update the PD link
  • sci_guy
    Member
    • Jan 2008
    • 83

    #2
    Updated details

    The advertisement is on the CSIRO Vacancies Hub.

    I've updated the position description document link above here. The updated PD contains a corrected position reference number. Please apply for job reference: 31121.

    The PD is also available via the above advertisement.

    PM me if you would like more info.

    Regards,
    Jason
    Last edited by sci_guy; 01-02-2017, 05:26 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM
    • GATTACAT
      Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by GATTACAT
      Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
      07-01-2026, 11:43 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    30 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    34 views
    0 reactions
    Last Post SEQadmin2  
    Working...